• Media type: E-Article
  • Title: Hepatocyte growth factor is upregulated by low-density lipoproteins and inhibits endothelin-1 release
  • Contributor: Haug, Cornelia; Schmid-Kotsas, Alexandra; Zorn, Ulrike; Bachem, Max G.; Schuett, Sabine; Gruenert, Adolf; Rozdzinski, Eva
  • imprint: American Physiological Society, 2000
  • Published in: American Journal of Physiology-Heart and Circulatory Physiology
  • Language: English
  • DOI: 10.1152/ajpheart.2000.279.6.h2865
  • ISSN: 0363-6135; 1522-1539
  • Keywords: Physiology (medical) ; Cardiology and Cardiovascular Medicine ; Physiology
  • Origination:
  • Footnote:
  • Description: <jats:p>Low-density lipoproteins (LDL) are known to cause endothelial injury and to promote the development of atherosclerotic lesions. This study demonstrates a significant concentration-dependent stimulatory effect of LDL on hepatocyte growth factor (HGF) synthesis (maximum release: 423 ± 16% of control) and HGF receptor mRNA expression in cultured human coronary artery endothelial cells (HCAEC). HGF is a potent mitogen for endothelial cells but does not affect smooth muscle cell proliferation. In contrast, endothelin-1 (ET-1) acts as a mitogen on vascular smooth muscle cells and seems to be upregulated in coronary atherosclerosis. In this study, the basal ET-1 synthesis in HCAEC was concentration-dependently reduced by HGF (minimum: 54 ± 3% of control). This inhibitory effect seems to be mediated via the tyrosine kinase activity of the HGF receptor c- met, since it was antagonized by the tyrosine kinase inhibitor lavendustin A. In addition, HGF also significantly reduced the LDL-stimulated ET-1 release. The LDL-induced upregulation of HGF synthesis in HCAEC and the inhibitory effect of HGF on ET-1 synthesis suggest a protective role of HGF in coronary atherosclerosis.</jats:p>
  • Access State: Open Access